Almac Discovery Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Almac Discovery Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011850
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Almac Discovery Ltd (Almac Discovery), a subsidiary of Almac Group Ltd is a healthcare service provider that discovers and develops drugs for the treatment of cancer. The company develops drugs, small molecule and therapeutic peptide, biomarkers and diagnostic tools. It provides early drug discovery and development services such as target finding, phase I clinical trials, lead optimization, preclinical development and clinical development. Almac Discovery’s pipeline products include ALM201, a microtubule binding agent in Phase 1 for the treatment of solid tumours; ALM301, a allosteric Akt inhibitor; and Wee-1 Inhibitor for the control of cell cycle. The company also conducts research on DNA repair and deubiquitinating enzymes. Almac Discovery is headquartered in Craigavon, the UK.

Almac Discovery Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Almac Discovery Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Almac Discovery Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Almac Discovery Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Almac Discovery Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Almac Discovery Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Almac Discovery Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Almac Discovery and Royal College of Surgeons in Ireland Enter into Research Agreement 10
McClay Foundation, Almac Discovery and University of Ulster Enter into Research Agreement 11
Elasmogen and Almac Discovery Enter into Co-Development Agreement 12
Almac Discovery Enters Into Agreement With Queen’s University Belfast For Drug Discovery 13
Beactica Enters Into Drug Discovery Agreement With Almac Discovery 15
Licensing Agreements 16
Debiopharm International Enters into Licensing Agreement with Almac Discovery 16
Genentech Enters into Licensing Agreement with Almac Discovery 17
Almac Discovery Enters Into Licensing Agreement With Shin Poong Pharma For ALM201 18
Almac Discovery Ltd – Key Competitors 19
Almac Discovery Ltd – Key Employees 20
Almac Discovery Ltd – Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Product News 22
Dec 04, 2017: Almac Discovery Publishes USP7 Inhibitors From UbiPlex Platform 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Almac Discovery Ltd, Pharmaceuticals & Healthcare, Key Facts, 2015 2
Almac Discovery Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Almac Discovery Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Almac Discovery Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Almac Discovery Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Almac Discovery Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Almac Discovery and Royal College of Surgeons in Ireland Enter into Research Agreement 10
McClay Foundation, Almac Discovery and University of Ulster Enter into Research Agreement 11
Elasmogen and Almac Discovery Enter into Co-Development Agreement 12
Almac Discovery Enters Into Agreement With Queen’s University Belfast For Drug Discovery 13
Beactica Enters Into Drug Discovery Agreement With Almac Discovery 15
Debiopharm International Enters into Licensing Agreement with Almac Discovery 16
Genentech Enters into Licensing Agreement with Almac Discovery 17
Almac Discovery Enters Into Licensing Agreement With Shin Poong Pharma For ALM201 18
Almac Discovery Ltd, Key Competitors 19
Almac Discovery Ltd, Key Employees 20

★海外企業調査レポート[Almac Discovery Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • State Bank Of India:企業の戦略・SWOT・財務分析
    State Bank Of India - Strategy, SWOT and Corporate Finance Report Summary State Bank Of India - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Advanced Accelerator Applications SA (AAAP):企業の財務・戦略的SWOT分析
    Summary Advanced Accelerator Applications SA (AAA), a Novartis company, is engaged in developing, producing and commercializing diagnostic and therapeutic molecular nuclear medicine products. The company’s lead product candidate comprises Lutathera, NETSPOT, SOMAKIT TOC, Gluscan, Gluscan 500, Barnas …
  • Medherant Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Medherant Ltd (Medherant) is a transdermal drug delivery patch company. The company develops and commercializes novel technologies for delivery of drugs through the skin using expertise in bioadhesives and polymer chemistry to treat pain, Alzheimer's disease, and for smoking cessation, hormo …
  • Vermont Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Vermont Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Caribbean Utilities Company, Ltd.:発電所・企業SWOT分析
    Caribbean Utilities Company, Ltd. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • GE Power India Ltd:企業の戦略・SWOT・財務情報
    GE Power India Ltd - Strategy, SWOT and Corporate Finance Report Summary GE Power India Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Ergon, Inc.:石油・ガス:M&Aディール及び事業提携情報
    Summary Ergon Inc (Ergon) is an integrated energy company that carries out the exploration and production of crude oil and natural gas, processing, transportation and terminaling of crude oil, storage, marketing and distribution of specialty petroleum products. The company also manufactures and mark …
  • LG International Corp (001120):企業の財務・戦略的SWOT分析
    LG International Corp (001120) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Mayo Foundation for Medical Education and Research:企業の戦略的SWOT分析
    Mayo Foundation for Medical Education and Research - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key compet …
  • ASKA Pharmaceutical Co Ltd (4514):製薬・医療:M&Aディール及び事業提携情報
    Summary ASKA Pharmaceutical Co Ltd (ASKA) is a pharmaceutical company that offers quasi-drugs, foods, medical devices and veterinary medicines. The company imports and export pharmaceuticals and medical devices. Its activities comprise production, drug information, and research and development servi …
  • 4P-Pharma SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary 4P-Pharma SAS (4P-Pharma) is a drug development company that offers drug pipeline for cancer and inflammatory diseases. The company’s pipeline product portfolio includes new chemical entities, biologics, added value generics and fixed dose combinations. Its pipeline candidates targets therap …
  • OGK-2 (OGKB):企業の財務・戦略的SWOT分析
    OGK-2 (OGKB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • JetBlue Airways Corp:企業の戦略・SWOT・財務情報
    JetBlue Airways Corp - Strategy, SWOT and Corporate Finance Report Summary JetBlue Airways Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Scope Metals Group Ltd:企業の戦略・SWOT・財務情報
    Scope Metals Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Scope Metals Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Daya Materials Bhd (DAYA):企業の財務・戦略的SWOT分析
    Summary Daya Materials Bhd (DMB) is a chemical company that offers polymer compound solutions. The company provides bulk chemicals, catalysts, additives, inert support materials and deodorizing agents. Its polymer compound products include semi conductive compounds, medium-voltage XLPE compounds, lo …
  • Mondi plc (MNDI):企業の財務・戦略的SWOT分析
    Mondi plc (MNDI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Nippon Yusen Kabushiki Kaisha (9101)-石油・ガス分野:企業M&A・提携分析
    Summary Nippon Yusen Kabushiki Kaisha (NYK) is a logistics company transporting crude oil and allied products. The company provides ocean, land, and air transport services for the transportation of petroleum products, liquid products and dry bulk products. Its portfolio includes line trade, air carg …
  • Universiteit Utrecht-製薬・医療分野:企業M&A・提携分析
    Summary Universiteit Utrecht (Universiteit Utrecht) is a research university that offers education programs. The university offers bachelors, master's, honor education, education for professionals, online education, training and other education courses. Its research areas include earth and sustainab …
  • Trivitron Healthcare Pvt Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Trivitron Healthcare Pvt Ltd (Trivitron) is a medical technology company that provides solutions to healthcare providers. The company’s products include radiography and c-arm systems, newborn screening, mammography, ultrasound, contrast media, breast biopsy system, bone densitometer, radiati …
  • Panoro Energy ASA (PEN):企業の財務・戦略的SWOT分析
    Summary Panoro Energy ASA (Panoro) is an independent oil and gas exploration and development company that explores, develops and produces oil and gas properties in Brazil and West Africa. The company holds interests in production and exploration assets in Santos and Camamu Almada basins in Brazil. I …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆